专利号:US-2024024489-A1 优先权日:2020-11-20 标 题:Protected disaccharides, their process of preparation and their use in the synthesis of zwitterionic oligosaccharides, and conjugates thereof 发明人:MULARD LAURENCE; DHARA DEBASHIS; PFISTER HELENE; PAOLETTI JULIE; PHALIPON ARMELLE; GUERREIRO-INVERNO CATHERINE 权利人:PASTEUR INSTITUT 摘要:The present invention provides zwitterionic oligosaccharides, in particular fragments of the surface polysaccharides from Shigella sonnei and Shigella sonnei conjugates comprising them. The present invention also provides protected disaccharides, their process of preparation and their use in the synthesis of zwitterionic oligosaccharides, and conjugates thereof, the disaccharide repeating unit of Shigella sonnei being: (I)
专利号:WO-2017100796-A1 优先权日:2015-12-11 标 题 :Modulation of globoseries glycosphingolipid synthesis and cancer biomarkers 发明人:WONG CHI-HUEY; HSU TSUI-LING; WU CHUNG-YI; CHEUNG SARAH K C; CHUANG PO-KAI 权利人:SINACA ACAD; WONG CHI-HUEY; HSU TSUI-LING 摘要:The present disclosure relates to methods and compositions which can modulate the globoseries glycosphingolipid synthesis. Particularly, the present disclosure is directed to glycoenzyme inhibitor compound and compositions and methods of use thereof that can modulate the synthesis of globoseries glycosphingolipid SSEA-3/SSEA-4/GloboH in the biosynthetic pathway; particularly, the glycoenzyme inhibitors target the alpha-4GalT; beta- 4GalNAcT-I; or beta-3GalT-V enzymes in the globoseries synthetic pathway. Additionally, the present disclosure is also directed to vaccines, antibodies, and/or immunogenic conjugate compositions targeting the SSEA-3/SSEA-4/GLOBO H associated epitopes (natural and modified) which elicit antibodies and/or binding fragment production useful for modulating the globoseries glycosphingolipid synthesis. Moreover, the present disclosure is also directed to the method of using the compositions described herein for the treatment or detection of hyperproliferative diseases and/or conditions. Furthermore, the instant disclosure also relates to cancer stem cell biomarkers for disgnostic and therapeutic uses.
专利号:US-2008145899-A1 优先权日:2004-09-17 标题 :Production of Oligosaccharides By Microorganisms 发明人:JOHNSON KARL; BYRNE NOEL J; DEFREES SHAWN 权利人:NEOSE TECHNOLOGIES INC 摘要:The present invention relates to the enzymatic synthesis of oligosaccharides, including sialylated product saccharides. In particular, it relates to the use of recombinant cells to take up low cost precursors such as glucose, pyruvate and N-actyl-glucosamine, and to synthesize activated sugar moieties that are used in oligosaccharide synthesis. The methods make possible the synthesis of many oligosaccharides using microorganisms and readily available, relatively inexpensive starting materials.
专利号:US-2017283878-A1 优先权日:2015-12-11 标题:Modulation of globoseries glycosphingolipid synthesis and cancer biomarkers 发明人:WONG CHI-HUEY; WU CHUNG-YI; CHEUNG SARAH K C; CHUANG PO-KAI; HSU TSUI-LING 权利人:ACADEMIA SINICA 摘要:The present disclosure relates to methods and compositions which can modulate the globoseries glycosphingolipid synthesis. Particularly, the present disclosure is directed to glycoenzyme inhibitor compound and compositions and methods of use thereof that can modulate the synthesis of globoseries glycosphingolipid SSEA-3/SSEA-4/GloboH in the biosynthetic pathway; particularly, the glycoenzyme inhibitors target the alpha-4GalT; beta-4GalNAcT-I; or beta-3GalT-V enzymes in the globoseries synthetic pathway. Additionally, the present disclosure is also directed to vaccines, antibodies, and/or immunogenic conjugate compositions targeting the SSEA-3/SSEA-4/GLOBO H associated epitopes (natural and modified) which elicit antibodies and/or binding fragment production useful for modulating the globoseries glycosphingolipid synthesis. Moreover, the present disclosure is also directed to the method of using the compositions described herein for the treatment or detection of hyperproliferative diseases and/or conditions. Furthermore, the instant disclosure also relates to cancer stem cell biomarkers for diagnostic and therapeutic uses.
专利号:WO-03064360-A1 优先权日:2002-02-01 标 题:Synthetic tetraethers and synthesis strategies therefor 发明人:KUEHL CHRISTINE; LITTGER RALF 权利人:BERNINA BIOSYSTEMS GMBH; KUEHL CHRISTINE; LITTGER RALF 摘要:The invention relates to novel synthetic tetraethers and a novel method for producing said substances. The inventive tetraethers are characterised in that they can be modified in a simple and targeted manner according to said synthesis method, which enabling the synthesis of the desired model substances. The synthesis concept guarantees high variability with simple individual production.
专利号:US-12377397-B2 优先权日:2020-06-16 标 题 :Systems, apparatus and kits for enzymatic polynucleotide synthesis 发明人:MARTIN CARL; ARTIGUE MARC; CRETON SANDRINE; DE CROZALS GABRIEL; GODRON XAVIER; HORGAN ADRIAN; LACHAIZE HENRI; LUCKEY JOHN; PEPONNET CHRISTINE; YBERT THOMAS 权利人:DNA SCRIPT 摘要:The invention is directed to systems, apparatus and kits for automated synthesis of a plurality of polynucleotides in an array of reaction chambers using a template-free polymerase. In some embodiments, adaptive elements and processes are provided to monitor and control disruption of the synthesis process and fluid movement by enzyme aggregation.
1: Ciano M, Fuszard M, Heide H, Botting CH, Galkin A. Conformation-specific crosslinking of mitochondrial complex I. FEBS Lett. 2013 Apr 2;587(7):867-72. doi: 10.1016/j.febslet.2013.02.039. Epub 2013 Feb 27. doi: 10.1021/ac401825m. Epub 2013 Oct 28. 3: Singh V, Mavila AK, Alam A. Effect of lysine residue modification of ovine luteinizing hormone by heterobifunctional crosslinking reagent SPDP on subunit-subunit association, receptor binding and biological activity. Indian J Exp Biol. 1992 Nov;30(11):1093-100. doi: 10.1016/j.jconrel.2011.06.003. doi: 10.1016/j.jconrel.2011.01.015. Epub 2011 Jan 22. doi: 10.1007/s10439-009-9734-x. Epub 2009 Jun 10.
合成参考文献
参考文献:10.1021/ac9603690 摘要:Matsunaga T, Kawasaki M, Yu X, Tsujimura N, Nakamura N. Chemiluminescence enzyme immunoassay using bacterial magnetic particles. Anal Chem. 1996 Oct 15;68(20):3551–4. doi: 10.1021/ac9603690. 参考文献:10.1021/bi9829534 摘要:Martin I, Pécheur EI, Ruysschaert JM, Hoekstra D. Membrane fusion induced by a short fusogenic peptide is assessed by its insertion and orientation into target bilayers. Biochemistry. 1999 Jul 20;38(29):9337–47. doi: 10.1021/bi9829534. 参考文献:10.1007/s007050050555 摘要:Amadori M, Archetti IL, Scaccaglia P, Modena D, Fossati G, Lucietto P, Mascagni P. Chaperonin 10 of Mycobacterium tuberculosis induces a protective immune response to foot-and-mouth disease virus. Arch Virol. 1999;144(5):905–19. doi: 10.1007/s007050050555. 参考文献:10.1007/s00216-008-2012-1 摘要:Sasaki K, Kogure K, Chaki S, Nakamura Y, Moriguchi R, Hamada H, Danev R, Nagayama K, Futaki S, Harashima H. An artificial virus-like nano carrier system: enhanced endosomal escape of nanoparticles via synergistic action of pH-sensitive fusogenic peptide derivatives. Analytical and Bioanalytical Chemistry. 2008 Mar 20;391(8):2717–27. doi: 10.1007/s00216-008-2012-1. 参考文献:10.1007/978-1-59745-178-9_19 摘要:Stoorvogel W. Analyzing endosomes in nonsectioned cells by transmission electron microscopy. Methods Mol Biol. 2008;440():247–57. doi: 10.1007/978-1-59745-178-9_19.